NASDAQ:ANIX | Free Cash Flow | Anixa Biosciences Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-10-31 to 2026-01-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-01-31-$2.61M
2025-10-31-$1.26M
2025-01-31-$2.9M
2024-10-31-$927,000.00
2024-01-31-$2.31M
2023-10-31-$1.97M
2023-01-31-$1.99M
2022-10-31-$1.59M
2022-01-31-$1.2M
2021-10-31-$1.05M
2021-01-31-$1.17M
2020-10-31-$1.41M$0.00-$1.41M
2020-01-31-$1.91M$15,790.00-$1.93M
2019-10-31-$1.34M$0.00-$1.34M
2019-01-31-$1.33M
2018-10-31-$1.02M$6,551.00-$1.03M
2018-01-31-$1.34M$2,518.00-$1.34M
2017-10-31-$739,288.00$13,303.00-$752,591.00
2017-01-31-$729,913.00$14,121.00-$744,034.00
2016-10-31-$682,994.00$1,871.00-$684,865.00
2016-01-31-$532,381.00$106,012.00-$638,393.00
2015-10-31-$801,925.00$0.00-$801,925.00
2015-01-31$4.65M$54,776.00$4.6M122.55%
2014-10-31-$362,082.00
2014-01-31-$1.17M
2013-10-31-$544,399.00
2013-01-31-$890,010.00
2012-10-31-$962,443.00$0.00-$962,443.00
2012-01-31-$657,257.00$850.00-$658,107.00
2011-10-31-$712,490.00$0.00-$712,490.00
2011-01-31-$609,649.00$6,246.00-$615,895.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-10-31-$7.17M
2024-10-31-$7.34M
2023-10-31-$6.21M
2022-10-31-$6.49M
2021-10-31-$4.94M
2020-10-31-$6.18M$15,791.00-$6.19M
2019-10-31-$4.74M$175,457.00-$4.92M
2018-10-31-$4.27M$38,404.00-$4.31M
2017-10-31-$3.8M$30,188.00-$3.83M
2016-10-31-$3.38M$146,521.00-$3.53M
2015-10-31$1.36M$54,776.00$1.31M
2014-10-31-$2.38M$6,684.00-$2.39M
2013-10-31-$3.19M
2012-10-31-$3.14M$1,600.00-$3.14M
2011-10-31-$716,000.00$9,028.00-$725,028.00
2010-10-31-$2.41M$2,069.00-$2.41M